Filing Details
- Accession Number:
- 0000014272-16-000417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-17 16:46:44
- Reporting Period:
- 2016-05-16
- Filing Date:
- 2016-05-17
- Accepted Time:
- 2016-05-17 16:46:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341069 | C Joseph Caldarella | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2016-05-16 | 3,519 | $72.47 | 55,238 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 1,719 | Indirect | By BMY Savings and Investment Program |
Footnotes
- Based on a plan statement as of the end of the most recent fiscal quarter